NICE MTG41 – Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain

NICE have released guidance and recommendations on a new spinal cord stimulation technology (MTG41)

We include a link to the specific guidance for the interest of the public and our members.  BASS fully supports a previous NICE recommendation (TA159) that any spinal cord stimulation should be provided only after an assessment by a multidisciplinary team experienced in chronic pain assessment and management of people with spinal cord stimulation devices, including experience in the provision of ongoing monitoring and support of the person assessed.

Profile Picture

UKSSB Executive Assistant


Forgot password

Not a member? Sign up here

Reset Password

Change Password

Sign Up

£50 for 1 year
£100 for 1 year
£50 for 1 year
Allied Health Professional
£50 for 1 year

Profile Picture